MANKIND.NS(MANKIND.NS)
MANKIND.NS
No analyst ratings available
No analyst price targets available for MANKIND.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $159.81B | $178.20B | $197.66B | $221.00B |
| Low | $157.01B | $171.90B | $190.11B | $214.49B |
| High | $164.87B | $191.67B | $203.87B | $231.95B |
| EBITDA Avg | $43.16B | $48.12B | $53.38B | $59.68B |
| Low | $42.40B | $46.42B | $51.34B | $57.92B |
| High | $44.52B | $51.76B | $55.06B | $62.64B |
| EBIT Avg | $36.49B | $40.69B | $45.14B | $50.47B |
| Low | $35.85B | $39.25B | $43.41B | $48.98B |
| High | $37.65B | $43.77B | $46.55B | $52.97B |
| Net Income Avg | $23.61B | $29.46B | $34.32B | $43.63B |
| Low | $21.30B | $24.67B | $30.77B | $41.96B |
| High | $25.87B | $34.26B | $39.14B | $46.44B |
| EPS Avg | $57.01 | $69.49 | $84.45 | $105.56 |
| Low | $51.53 | $59.68 | $74.45 | $101.51 |
| High | $62.60 | $82.89 | $94.69 | $112.36 |
| Analysts (Rev / EPS) | 18 / 16 | 19 / 17 | 7 / 6 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $41.62B | $40.26B | $39.20B |
| Low | $41.62B | $40.26B | $39.20B |
| High | $41.62B | $40.26B | $39.20B |
| EBITDA Avg | $11.24B | $10.87B | $10.58B |
| Low | $11.24B | $10.87B | $10.58B |
| High | $11.24B | $10.87B | $10.58B |
| EBIT Avg | $9.50B | $9.19B | $8.95B |
| Low | $9.50B | $9.19B | $8.95B |
| High | $9.50B | $9.19B | $8.95B |
| Net Income Avg | $7.15B | $3.58B | $8.35B |
| Low | $7.15B | $3.58B | $8.35B |
| High | $7.15B | $3.58B | $8.35B |
| EPS Avg | $17.30 | $8.65 | $20.19 |
| Low | $17.30 | $8.65 | $20.19 |
| High | $17.30 | $8.65 | $20.19 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |